At Farname-Diganosis, our shared goal is to address the critical need for a standardized, cost-effective method for early ovarian cancer diagnosis. By combining expertise in biosensor development, clinical diagnostics, and women’s health, our interdisciplinary team is dedicated to advancing global health and improving patient survival rates.

Leadership

Farname- Diagnosis was founded by Dr. Soha Ahmadi, Prof. Michael Thompson, and Prof. Mohammadreza Jalali—experts with strong scientific and academic backgrounds. Dr. Ahmadi launched Farname-Diagnosis to create cutting-edge point-of-care devices for rapid, accurate diagnostics. Prof. Thompson, a bioanalytical chemist and surface chemistry pioneer, is renowned for developing antifouling surfaces for biomedical applications and sensing devices. Prof. Jalali, a medical doctor and specialist in pathology and medical laboratory sciences, provides critical clinical expertise to ensure practical, innovative solutions. Together, they are committed to enhancing patient outcomes and empowering healthcare providers with advanced, accessible technologies.

Dr. Soha Ahmadi

Dr. Soha Ahmadi is a distinguished postdoctoral researcher at the University of Toronto’s Department of Chemistry. With a robust background in bioanalytical chemistry, Dr. Ahmadi has made significant contributions to the field through her innovative work on developing electrochemical biosensors for a variety of applications.

Currently, Dr. Ahmadi is focused on pioneering point-of-care devices aimed at the early detection of ovarian cancer. Her work in this area is driven by a commitment to improving diagnostic methods and enhancing patient outcomes.

To learn more about Dr. Ahmadi research contributions, you can explore her publications through her ORCID profile:

https://orcid.org/0000-0002-7182-9049

Prof. Michael Thompson

Professor Michael Thompson is a renowned bioanalytical chemist in the Department of Chemistry at the University of Toronto, with adjunct roles at Tyndall National Institute and the Universities of Limerick and Liverpool.

He is a pioneer in developing antifouling coatings for biosensors and medical devices and has spent the past decade advancing diagnostic methods for early ovarian cancer detection, including electrochemical, fluorescence, and acoustic wave techniques.

To explore Prof. Thompson’s extensive research contributions, visit his academic profile:

https://thompson.chem.utoronto.ca/research

Prof. Mohammadreza Jalali

Professor Mohammadreza Jalali is a distinguished medical doctor and researcher. With a background in pathology and 25 years of clinical and academic experience, he has made significant contributions to the field of pathology and clinical diagnosis.

Currently, Prof. Jalali is focused on clinical trials for point-of-care devices aimed at improving diagnostic methods and enhancing patient outcomes.

Our Collaborator

Thompson Research Lab

Thompson Research Lab primarily focuses on the development of innovative sensing platforms for the label-free detection of biochemical events at the liquid-solid interface. These projects are highly interdisciplinary, encompassing areas such as bioanalytical chemistry, biocompatibility, engineering, biochemistry, and surface chemistry

Their pioneering efforts have led to significant advancements in biosensing and clinical diagnostics, particularly in the detection of biomarkers for various diseases. Their current research includes the development of ultra-high frequency acoustic wave systems for the early detection of ovarian cancer. This groundbreaking work aims to improve early diagnosis and patient outcomes.

They actively collaborate with several research groups globally. Their notable collaborations include working with the Princess Margaret Cancer Centre on early-stage detection of ovarian cancer, and with the Tyndall National Institute in Ireland on developing electrochemical biosensors.